Like said above, Canada is a small market, companies discount to sell there partially because it's not worth the effort to try to charge more. Why sell any at all then, right?
To prevent Canada, Mexico, every other smaller market country in the world from doing what Brazil is doing.
From here
If you don't sell to smaller markets, they'll reverse engineer what they want, patents be damned. Same if they sold at US rates. So they end up selling at a discount to prevent being ripped off entirely.
People keep saying Medicare should negotiate the same discounts. That's fine, so now the drug companies don't have a full rate market anywhere (or have a few full rate markets that aren't going to keep up with the loss of the US) and revenue falls. R&D slows, new drugs don't come to market. Are they making huge profits now? Yeah. Is that fair? Yeah, under our system of government so far it is. I'm not completely without sympathy for the ongoing medical bills of people needing life sustaining drug therapy, but price controls don't encourage development.
How many drugs on the market today came out of the USSR? A few come out of the UK and France, but at a much lower rate than the US.
To prevent Canada, Mexico, every other smaller market country in the world from doing what Brazil is doing.
But burdened by the steep cost of imported AIDS medications, Brazil in 1998 gave Far-Manguinhos's director, Eloan Pinheiro, a mandate: analyze brand-name drugs and develop generic forms of them. The decision has put Far-Manguinhos under the international spotlight and set a new standard for excellence in the developing world. Brazil is the only country in Latin America whose public institutions manufacture AIDS drugs on a large scale.
From here
If you don't sell to smaller markets, they'll reverse engineer what they want, patents be damned. Same if they sold at US rates. So they end up selling at a discount to prevent being ripped off entirely.
People keep saying Medicare should negotiate the same discounts. That's fine, so now the drug companies don't have a full rate market anywhere (or have a few full rate markets that aren't going to keep up with the loss of the US) and revenue falls. R&D slows, new drugs don't come to market. Are they making huge profits now? Yeah. Is that fair? Yeah, under our system of government so far it is. I'm not completely without sympathy for the ongoing medical bills of people needing life sustaining drug therapy, but price controls don't encourage development.
How many drugs on the market today came out of the USSR? A few come out of the UK and France, but at a much lower rate than the US.